Single-cell sequencing refers to the amplification and sequencing of transcriptomes or genomes at the level of individual cells to detect single cells in the genome (Structural Variations-SVs; Copy number variants-CNVs; Single Nucleotide Variants-Single nucleotide variants-SNVs, etc.), transcriptomics (RNA expression level; alternative splicing of transcripts), epiomics (DNA methylation, etc.), proteomics and multiple omics data...
Single Cell Sequencing Platform Market contains market size and forecasts of Single Cell Sequencing Platform in Global, including the following market information:
- Global Single Cell Sequencing Platform Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Single Cell Sequencing Platform market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Microfluidic Separation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Single Cell Sequencing Platform include 10x Genomics, BD, Fluidigm Corporation, Illumina/Bio-Rad, Takara Bio, 1CellBio and MissionBio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- surveyed the Single Cell Sequencing Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single Cell Sequencing Platform Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Single Cell Sequencing Platform Market Segment Percentages, by Type, 2021 (%)
- Microfluidic Separation
- Microdroplet Separation
- Microporous Separation
- Combined Labeling
- Other
Global Single Cell Sequencing Platform Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Single Cell Sequencing Platform Market Segment Percentages, by Application, 2021 (%)
- Neurobiology
- Immunology
- Cancer Medicine
- Plant Biology
- Forensics
- Other
Global Single Cell Sequencing Platform Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Single Cell Sequencing Platform Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Single Cell Sequencing Platform revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Single Cell Sequencing Platform revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 10x Genomics
- BD
- Fluidigm Corporation
- Illumina/Bio-Rad
- Takara Bio
- 1CellBio
- MissionBio